Prevalence and Preoperative Characteristics Associated with Complicated Appendicitis Among Children Undergoing Appendectomy in Southwestern Saudi Arabia: A Hospital-Based Cross-Sectional Study
Abstract
Background/Objectives: Complicated appendicitis carries greater morbidity than uncomplicated disease, yet its prevalence and determinants in southwestern Saudi Arabia are largely undocumented. This study estimated the prevalence of complicated appendicitis among children undergoing appendectomy and identified the preoperative characteristics independently associated with it. Methods: A hospital-based cross-sectional study included 275 children aged 14 years or younger who underwent appendectomy at King Fahd Central Hospital, Jazan, between January 2020 and December 2024. Complicated appendicitis was defined by appendiceal perforation, purulent intra-abdominal collection, or generalized peritonitis documented in the structured intraoperative record. Prevalence is reported with Wilson 95% confidence intervals. Adjusted prevalence ratios (aPR) with 95% confidence intervals were estimated by modified Poisson regression with robust variance, using preoperative variables selected for clinical plausibility. Two sensitivity analyses used broader outcome definitions. Results: Complicated appendicitis was present in 57 of 275 children, a prevalence of 20.7% (16.4–25.9). Prevalence did not differ by age group, sex, referral status, or symptom duration, but was higher among urban than rural residents (26.3% vs. 15.2%, p = 0.035). Two preoperative characteristics were independently associated with complicated disease: generalized abdominal tenderness (aPR 3.01, 1.75–5.20) and reported…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 275 participants or records.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.